Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Electromagnetic Compatibility Guidance Finalized

Executive Summary

In the final medical device electromagnetic compatibility guidance FDA clarified the scope of applications that could use this guidance and added a recommendation for sponsors to identify and consider the intended use environmental that could affect the EMC of their products.

Advertisement

Related Content

FDA Declines To Add 510(k)s To Pediatric Data Guidance, But Does Address De Novos
Special Controls Set By FDA For External Pacers, Analyzers
US FDA Recognizes 46 New Medical Device Standards To Support Pre-Market Reviews
Cranial Stimulators Split By FDA Into Class III For Depression And Class II For Anxiety/Insomnia
Avoiding Electromagnetic Interference: FDA Issues Draft Guidance
Podcast: FDA, Med Institute Studying MRI Safety of Passive Devices
CDRH Launches Expedited Access Pathway, Extends To De Novos

Topics

Advertisement
UsernamePublicRestriction

Register

MT103583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel